Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomerica

0.6215
+0.04908.56%
Post-market: 0.64850.0270+4.34%19:58 EDT
Volume:198.71K
Turnover:121.73K
Market Cap:11.40M
PE:-1.87
High:0.6400
Open:0.5900
Low:0.5725
Close:0.5725
Loading ...

Biomerica achieves IVDR certification in European union

TIPRANKS
·
26 Feb

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

GlobeNewswire
·
26 Feb

BRIEF-Biomerica’S Infoods® IBS Clinical Trial Results Published And Featured In Gastroenterology, The Leading Gi Medical Journal

Reuters
·
19 Feb

Biomerica’s Infoods® Ibs Clinical Trial Results Published and Featured in Gastroenterology, the Leading Gi Medical Journal

THOMSON REUTERS
·
19 Feb

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

GlobeNewswire
·
19 Feb

January 2025 US Penny Stocks With Promising Potential

Simply Wall St.
·
18 Jan

Sector Update: Health Care Stocks Rise Thursday Afternoon

MT Newswires Live
·
17 Jan

Top Midday Gainers

MT Newswires Live
·
17 Jan

US Stocks Edge Lower; Retail Sales Increase Less Than Expected

Benzinga
·
16 Jan

Biomerica Says UAE Health Ministry Approved Prostrate Cancer Detection Test

MT Newswires Live
·
16 Jan

Biomerica: United Arab Emirates Ministry of Health and Prevention Approves Fortel Psa Screening Test to Detect Early Sign of Prostate Cancer

THOMSON REUTERS
·
16 Jan

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

GlobeNewswire
·
16 Jan

Biomerica Second Quarter 2025 Earnings: US$0.055 loss per share (vs US$0.09 loss in 2Q 2024)

Simply Wall St.
·
16 Jan

Biomerica reports Q2 EPS (6c) vs. (9c) last year

TIPRANKS
·
15 Jan

Biomerica Q2 2025 Revenue $1.64M Vs $1.57M YoY; EPS $(0.06) Vs $(0.09) YoY

Benzinga
·
15 Jan

BRIEF-Biomerica Q2 Net Income USD -950 Thousand

Reuters
·
15 Jan